These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2141109)

  • 21. Carnitine depletion during chronic hemodialysis: effect of substitution on free carnitine plasma levels.
    Broquet PE; Von Moos C; Frei J; Gobelet C; Wauters JP
    Adv Exp Med Biol; 1987; 223():287-90. PubMed ID: 3447448
    [No Abstract]   [Full Text] [Related]  

  • 22. [Protective role of carnitine in acetate metabolism of patients with uremia treated by hemodialysis].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1997 Jun; 97(6):534-40. PubMed ID: 9441289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma parameters of the prothrombotic state in chronic uremia.
    Sagripanti A; Cupisti A; Baicchi U; Ferdeghini M; Morelli E; Barsotti G
    Nephron; 1993; 63(3):273-8. PubMed ID: 8446263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ticlopidine on coagulation and platelet functions during hemodialysis with cuprophan membranes.
    Grekas D; Syrganis C; Romtsou S; Makris P; Tsakiris DA; Tourkantonis A
    Life Support Syst; 1985; 3 Suppl 1():409-13. PubMed ID: 2959822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling.
    Díaz-Ricart M; Estebanell E; Cases A; Calls J; López-Pedret J; Carretero M; Castillo R; Ordinas A; Escolar G
    Kidney Int; 2000 May; 57(5):1905-14. PubMed ID: 10792609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of l-carnitine supplement on serum amyloid A and vascular inflammation markers in hemodialysis patients: a randomized controlled trial.
    Tabibi H; Hakeshzadeh F; Hedayati M; Malakoutian T
    J Ren Nutr; 2011 Nov; 21(6):485-91. PubMed ID: 21439850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological use of L-carnitine in uremic anemia: has its full potential been exploited?
    Bonomini M; Zammit V; Pusey CD; De Vecchi A; Arduini A
    Pharmacol Res; 2011 Mar; 63(3):157-64. PubMed ID: 21138768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral carnitine supplementation for dyslipidemia in chronic hemodialysis patients.
    Naini AE; Sadeghi M; Mortazavi M; Moghadasi M; Harandi AA
    Saudi J Kidney Dis Transpl; 2012 May; 23(3):484-8. PubMed ID: 22569432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered circadian rhythm of platelet aggregation in hemodialyzed patients.
    Rydzewski A; Małyszko J; Borawski J; Pawlak D; Azzadin A; Buczko W; Myśliwiec M
    Nephron; 1997; 77(3):365-7. PubMed ID: 9375838
    [No Abstract]   [Full Text] [Related]  

  • 32. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.
    Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C
    Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients.
    Bellinghieri G; Savica V; Mallamace A; Di Stefano C; Consolo F; Spagnoli LG; Villaschi S; Palmieri G; Corsi M; Maccari F
    Am J Clin Nutr; 1983 Oct; 38(4):523-31. PubMed ID: 6624694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of L-carnitine supplementation in hemodialysis patients.
    Veselá E; Racek J; Trefil L; Jankovy'ch V; Pojer M
    Nephron; 2001 Jul; 88(3):218-23. PubMed ID: 11423752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
    Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
    Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid metabolism in non-uremic and uremic dogs during and after hemodialysis with acetate.
    Morin RJ; Guo LS; Rorke SJ; Davidson WD
    J Dial; 1978; 2(2):113-29. PubMed ID: 681578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bezafibrate on lipids, lipoproteins, apolipoproteins and platelet aggregation in hypertriglyceridemic patients.
    Waysbort J; Schwartz S; Brunner D
    Arzneimittelforschung; 1994 Nov; 44(11):1217-22. PubMed ID: 7893284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.